Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "ELISA Diagnostic Tests Market (2024 Edition): Analysis By Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, Others Types), By Application, By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.
This report provides an analysis for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.
The Global ELISA Diagnostic Tests market showcased growth at a CAGR of 5.88% during 2020-2023. The market was valued at USD 1.52 billion in 2023 which is expected to reach USD 2.43 billion in 2030.
ELISA diagnostic tests market is experiencing robust growth, driven by advancements in healthcare infrastructure, the rising prevalence of infectious and chronic diseases, and the increasing need for cost-effective diagnostic solutions. Increasing diagnosis rates, greater awareness, and improved access to healthcare are contributing to rising epilepsy prevalence worldwide. Aging populations and the higher incidence of epilepsy in both the very young and elderly are further driving demand for effective therapeutics.
The global ELISA diagnostics market is projected to grow significantly, with its adoption driven by the increasing burden of diseases such as HIV, hepatitis, and autoimmune conditions. The test's reliability, sensitivity, and adaptability to various sample types make it a preferred choice in clinical and research settings.
Americas leads the market due to advanced healthcare infrastructure and government funding, while Europe follows with strong R&D capabilities and healthcare initiatives. Emerging markets in Asia-Pacific and the Middle East and Africa are witnessing accelerated growth, spurred by improved healthcare access and rising awareness of early disease detection.
Scope of the Report
- The report analyses the ELISA Diagnostic Tests Market by Value (USD Million).
- The report analyses the ELISA Diagnostic Tests Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
- The report presents the analysis of ELISA Diagnostic Tests Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
- The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Test Type, By Application and By End Users.
- Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development.
Analyst Recommendations
- Customized Disease-Specific ELISA Kits
- Eco-Friendly and Sustainable ELISA Products
ELISA Diagnostic Tests Market: Historic and Forecast
- Impact Analysis of Macro Economic Factors on ELISA Diagnostic Tests Market
- Global Incidence of COVID-19
- Global Incidence of HIV/AIDS
- SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
- Global ELISA Diagnostic Tests Market: Dashboard
- Global ELISA Diagnostic Tests Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
- Global ELISA Diagnostic Tests Market: Market Value Assessment
- Global ELISA Diagnostic Tests Market Segmentation: By Test Type
- Global ELISA Diagnostic Tests Market, By Test Type Overview
- Global ELISA Diagnostic Tests Market Attractiveness Index, By Test Type
- Sandwich ELISA, By Value, 2020H-2030F (USD Million & CAGR)
- Indirect ELISA, By Value, 2020H-2030F (USD Million & CAGR)
- Competitive ELISA, By Value, 2020H-2030F (USD Million & CAGR)
- Other types, By Value, 2020H-2030F (USD Million & CAGR)
- Global ELISA Diagnostic Tests Market Segmentation: By Application
- Global ELISA Diagnostic Tests Market, By Application Overview
- Global ELISA Diagnostic Tests Market Attractiveness Index, By Application
- Autoimmune diseases, By Value, 2020H-2030F (USD Million & CAGR)
- Infectious Diseases, By Value, 2020H-2030F (USD Million & CAGR)
- Cancer Diagnosis, By Value, 2020H-2030F (USD Million & CAGR)
- Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
- Global ELISA Diagnostic Tests Market Segmentation: By End Users
- Global ELISA Diagnostic Tests Market, By End Users Overview
- Global ELISA Diagnostic Tests Market Attractiveness Index, By End Users
- Human, By Value, 2020H-2030F (USD Million & CAGR)
- Veterinary, By Value, 2020H-2030F (USD Million & CAGR)
Competitive Positioning
- Companies' Product Positioning
- Market Position Matrix
- Market Share Analysis of ELISA Diagnostic Tests Market
Company Profiles
- QIAGEN
- F. Hoffmann-La Roche AG
- PerkinElmer Inc.
- Abbott Laboratories
- Thermo Fisher Scientific
- Becton, Dickinson and Company
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Enzo Life Sciences, Inc.
- Innovative Diagnostics SAS
For more information about this report visit https://www.researchandmarkets.com/r/rtky29
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
